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INTRODUCTION

Staphylococcus aureus and Coagulase Negative
Staphylococci (CONS) are recognized to be most common cause of nosocomial and community acquired infections in every region of the world. The increasing prevalence of Methicillin resistant among staphylococci is a global problem.
isolates, but recent reports of resistance to these agents raise real concerns over how long these uniform susceptibilities will hold good. 4, 5 This has led to renewed interest in the usage of macrolide (e.g., erythromycin)-lincosamide (e.g., Clindamycin)-streptogramin B (e.g., quinupristindalfopristin) (collectively called as MLSB family) antibiotics to treat Staphylococcus aureus (S. aureus) infections with, clindamycin being the preferred agent due to its excellent pharmacokinetic properties. Staphylococcal strains resistant to MLSB antibiotics have increased in number following the widespread use of these antibiotics for treating serious staphylococcal infections. 6 Resistance occurs by different mechanisms to these microbiologically related antibiotics. Resistance due to active efflux encoded by msr (A) gene confers resistance to macrolides and streptogramin B (MS phenotype) but not to clindamycin. Ribosomal target modification, another mechanism of resistance, confers resistance to macrolide, type B streptogramin and also to clindamycin (MLSB phenotype). MLSB resistance in staphylococci is either constitutive (c), where rRNA methylase is always produced or inducible (iMLSB), where methylase is only produced in the presence of an inducer, and is encoded by erm (A) or erm (C) gene. 7, 8 The resistance is constitutive (cMLSB) when R-methylase is produced and inducible (iMLSB) (MLSB)when methylase is produced only in the presence of an inducing agent. Erythromycin is a very effective inducer and Clindamycin is a weak inducer. 9 Patients infected with iMLSB (MLSB)strains of staphylococcus if treated with clindamycin can develop constitutive resistance during therapy and subsequently result in treatment failure. 10 Detection of three resistant phenotypes (MS, iMLSB, cMLSB) is crucial for guiding appropriate antimicrobial therapy. Constitutive resistance can be detected by routine disc diffusion method but it fails to detect inducible resistance (iMLSB), which appears sensitive to clindamycin on routine testing, resulting in institution of inappropriate clindamycin therapy. Inducible resistance also cannot be detected by broth or agar dilution methods. A negative result for inducible clindamycin resistance (ICR) by D test confirms clindamycin susceptibility and provides a good therapeutic option, thus necessitates the detection of inducible clindamycin resistance. 12 Incidence of clindamycin resistance varies from place to place and therefore a local data is important to guide empirical treatment. 13 Data describing prevalence of clindamycin resistance among clinical isolates of S. aureus and CONS is lacking from our geographic area. So this study demonstrates simple, reliable and significant method (double disc diffusion test) of detecting inducible resistance to Clindamycin in isolates of S. aureus and CONS.
MATERIALS AND METHODS
Methods: A prospective study was conducted from March 2015 to December 2015 at Chitwan Medical College Teaching Hospital (a 600 bed teaching hospital), Chitwan, Nepal. Sample collection: The samples were collected in sterile containers using aseptic technique and transported to the laboratory without delay. All samples were processed immediately. A total of 264 non duplicate clinical isolates of erythromycin resistant Staphylococcus species isolated from samples received from various outpatient and inpatient departments of the hospital were included in the study. Culture and bacterial identification: For the isolation and identification of Staphylococcus species several media used were blood agar (BA), chocolate agar (CHA), MacConkey agar (MA), brain heart infusion (BHI) broth (for blood sample), DNase agar and mannitol salt agar (HiMedia Laboratories Pvt. Limited, India) and the tests used were catalase and coagulase. The collected samples were inoculated onto different culture media. The CHA plates were incubated in a CO2 incubator (10% CO2) at 37°C for 24 hours. The BA and MA plates were incubated at 37°C for 24 
RESULTS
Out of 264
Erythromycin resistant staphylococcus species, 213 were S. aureus and 51 were CONS. Majority of the samples 57.9% were received from inpatient department and 42% from outpatient department. Most of the staphylococcus species were found in age group one to 10 years as shown in Figure 1 . Staphylococcus species were most commonly isolated form blood sample 44.6% followed by pus/exudate 23.4%, urine 11.7%, and sputum 10.2% as shown in Figure 2 17 Erythromycin is most commonly used drug for treatment of both minor and major serious staphylococcal infections. Due to increasing burden of erythromycin resistance there is very limited therapeutic option left for treatment of staphylococcal infections. Clindamycin is most preferred drug for treatment of MRSA infections. 18 Macrolide resistant staphylococcus species may show constitutive or inducible resistance to clindamycin or may be resistance to only macrolides. However, there has been increase in inducible clindamycin resistance among erythromycin resistant clinical isolates of staphylococcus species. Staphylococcal species with clindamycin resistance can develop inducible phenotype, and gradually from such isolates, spontaneous constitutively resistant mutants have arisen both in vitro and in vivo during clindamycin therapy. More over negative result for inducible clindamycin resistance confirms clindamycin susceptibility and good therapeutic option for treatment of both MRSA and MSSA. Hence, detection of such resistant phenotypes is of utmost importance to minimize treatment failures. 19 Maximum (34.4%) of staphylococcus species were isolated from age group 0 to 10 years . Majority of the staphylococcus species 44.6% were isolated from blood sample followed by pus/exudates 23.4% which shows the role of staphylococcus species in bloodstream infections and abscess formation. These findings are in concordance with study conducted by Faisal et al. 20 Various other investigators reported that majority of staphylococcus species were recovered from pus and urine samples respectively. 21, 22 This shows the variation among staphylococcus isolates recovered from clinical samples in different healthcare setting.
In our study among 264 erythromycin resistant staphylococcus species, 213 (80.6%) were S. aureus and 51 (19.3%) were CONS. In present study Constitutive MLSB phenotype was most predominant phenotype 48.4% followed by Inducible MLSB phenotype 41.2% and MS phenotype 10.2% among staphylococcus species. Various other investigators reported the similar results. 23 Out of 213 erythromycin resistant isolates of S. aureus, 140 (65.7%) were MRSA and 73 (34.2%) were MSSA whereas out of 51 erythromycin resistant isolates of CONS, 28 (54.9%) were MRCNS and 23 (45%) were MSCNS. There is high prevalence of Constitutive MLSB phenotype and Inducible MLSB phenotype among both MRSA and MRCNS isolates. Similar pattern has been observed in earlier studies. 24, 25 Also khan et al reported that Constitutive MLSB phenotype and Inducible MLSB phenotype was higher among both MRSA and MRCNS isolates. 26 MS phenotype was more predominant among 11 (5.1%) MSSA and 5 (9.8%) MSCNS isolates compared to 9 (4.2%) in MRSA and 2 (3.9%) in MRCNS which is in concordance with study done by other investigators. 27 The variation of the results depends upon the sample size, age group, geographical region, population studied and antibiotic profile. The prevalence of inducible clindamycin resistance varies among different hospital setting. So this study was conducted to determine inducible clindamycin resistance in our locality. The present study demonstrates the high prevalence of Constitutive MLSB phenotype and Inducible MLSB phenotype among both MRSA and MRCNS isolates. There is very limited therapeutic option available for treatment of MRSA infections, clindamycin being more preferred than vancomycin. Hence, true sensitivity to clindamycin can be judged by performing simple 'D' test for all erythromycin resistant staphylococcus species. Therefore, by performing this simple test routinely clindamycin treatment failure can be greatly prevented.
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